Ligand Pharmaceuticals, Inc. (LGND)
188.06
-1.01
(-0.53%)
USD |
NASDAQ |
Jan 02, 13:56
Ligand Pharmaceuticals Total Liabilities (Quarterly): 526.60M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 77.64B |
| Johnson & Johnson | 113.54B |
| Inspire Medical Systems, Inc. | 141.26M |
| Elanco Animal Health, Inc. | 6.802B |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.477B |
| Shareholders Equity (Quarterly) | 950.17M |
| Debt to Equity Ratio | 0.4746 |
| Current Ratio | 24.69 |
| Net Debt Paydown Yield | -2.55% |